This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachoual, R.
Right arrow Articles by Tankovic, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachoual, R.
Right arrow Articles by Tankovic, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2000, p. 1842-1845, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Roles of gyrA Mutations in Resistance of Clinical Isolates and In Vitro Mutants of Bacteroides fragilis to the New Fluoroquinolone Trovafloxacin

Rafik Bachoual,1 Luc Dubreuil,2 Claude-James Soussy,1 and Jacques Tankovic1,*

Service de Bactériologie-Virologie-Hygiène, Hôpital Henri Mondor, Créteil,1 and Faculté de Pharmacie, Lille,2 France

Received 1 February 2000/Returned for modification 30 March 2000/Accepted 21 April 2000

We determined whether gyrA mutations were present in fluoroquinolone-resistant laboratory mutants derived from the Bacteroides fragilis reference strain ATCC 25285 and in clinical isolates of B. fragilis. The two first-step mutants selected on ciprofloxacin (CIP) were devoid of gyrA mutations, whereas two of the three CIP-selected second-step mutants studied presented the same gyrA mutation leading to a Ser82Phe change. Unusual GyrA alterations, Asp81Asn or Ala118Val, were detected in two of the three first-step mutants selected on trovafloxacin (TRO), Mt3 and Mt1, respectively. The Ala118Val change had no effect on the susceptibility of Mt1 to CIP. No second-step mutant could be obtained with TRO as a selector. For the 12 clinical isolates studied, a Ser82Phe change in GyrA was found only in the 3 strains which showed the highest levels of TRO resistance (MIC, 4 µg/ml). Thus, the resistance phenotypes and genotypes observed in fluoroquinolone-resistant clinical isolates of B. fragilis were similar to those found in CIP-selected laboratory mutants, whereas peculiar mutational events could be selected in vitro with TRO.

* Corresponding author. Mailing address: Service de Bactériologie-Virologie-Hygiène, Hôpital Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94 010 Créteil, France. Phone: 33-1-49812828. Fax: 33-1-49812839. E-mail: jacques.tankovic{at}hmn.ap-hop-paris.fr.

Antimicrobial Agents and Chemotherapy, July 2000, p. 1842-1845, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Peric, M., Jacobs, M. R., Appelbaum, P. C. (2004). Antianaerobic Activity of a Novel Fluoroquinolone, WCK 771, Compared to Those of Nine Other Agents. Antimicrob. Agents Chemother. 48: 3188-3192 [Abstract] [Full Text]  
  • Ricci, V., Peterson, M. L., Rotschafer, J. C., Wexler, H., Piddock, L. J. V. (2004). Role of Topoisomerase Mutations and Efflux in Fluoroquinolone Resistance of Bacteroides fragilis Clinical Isolates and Laboratory Mutants. Antimicrob. Agents Chemother. 48: 1344-1346 [Abstract] [Full Text]  
  • Peterson, M. L., Rotschafer, J. C., Piddock, L. J. V. (2003). Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis. J Antimicrob Chemother 52: 481-484 [Abstract] [Full Text]  
  • Dridi, L., Tankovic, J., Burghoffer, B., Barbut, F., Petit, J.-C. (2002). gyrA and gyrB Mutations Are Implicated in Cross-Resistance to Ciprofloxacin and Moxifloxacin in Clostridium difficile. Antimicrob. Agents Chemother. 46: 3418-3421 [Abstract] [Full Text]  
  • Miyamae, S., Ueda, O., Yoshimura, F., Hwang, J., Tanaka, Y., Nikaido, H. (2001). A MATE Family Multidrug Efflux Transporter Pumps out Fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob. Agents Chemother. 45: 3341-3346 [Abstract] [Full Text]  
  • Friedman, S. M., Lu, T., Drlica, K. (2001). Mutation in the DNA Gyrase A Gene of Escherichia coli That Expands the Quinolone Resistance-Determining Region. Antimicrob. Agents Chemother. 45: 2378-2380 [Abstract] [Full Text]  
  • Oh, H., El Amin, N., Davies, T., Appelbaum, P. C., Edlund, C. (2001). gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains. Antimicrob. Agents Chemother. 45: 1977-1981 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»